CYHS2000288 | 非布司他片 | febuxostat | Tablet | Chemical Drugs(4) | Generic Drug | 2020-05-06 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-15 | view |
CYHS2000287 | 非布司他片 | febuxostat | Tablet | Chemical Drugs(4) | Generic Drug | 2020-05-06 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-15 | view |
CYHS2000644 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2020-09-24 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-15 | view |
CYHS2000643 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2020-09-24 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-15 | view |
CYHB2050491 | 注射用盐酸头孢吡肟 | cefepime hydrochloride | Lyophilized | Chemical Drugs(原4) | Supplementary Application | 2020-08-12 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-01 | view |
CYHB2005817 | 注射用盐酸头孢吡肟 | cefepime hydrochloride | Lyophilized | Chemical Drugs(原4) | Supplementary Application | 2020-07-28 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-12-01 | view |
CYHS2000156 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(4) | Generic Drug | 2020-02-29 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-10-29 | view |
CYHS2000524 | 氢溴酸伏硫西汀片 | vortioxetine hydrobromide | Tablet | Chemical Drugs(4) | Generic Drug | 2020-07-24 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-10-29 | view |
CYHS1900772 | 恩曲他滨丙酚替诺福韦片 | emtricitabine;tenofovir alafenamide | Tablet | Chemical Drugs(4) | Generic Drug | 2019-11-11 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-10-25 | view |
CYHB1950559 | 注射用头孢美唑钠 | cefmetazole sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-08-10 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHB2011695 | 头孢克肟胶囊 | cefixime | Capsule | Chemical Drugs | Supplementary Application | 2021-01-01 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHB1950560 | 注射用头孢美唑钠 | cefmetazole sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-08-10 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHB2140009 | 注射用头孢唑林钠 | cefazolin sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-03-10 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHS1900686 | 盐酸右美托咪定氯化钠注射液 | Dexmedetomidine Hydrochloride | Injection | Chemical Drugs(3) | Generic Drug | 2019-10-08 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Approval | 2021-07-05 | view |
CYHS1900685 | 盐酸右美托咪定氯化钠注射液 | Dexmedetomidine Hydrochloride | Injection | Chemical Drugs(3) | Generic Drug | 2019-10-08 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Approval | 2021-07-05 | view |
CYHS1900687 | 盐酸右美托咪定氯化钠注射液 | Dexmedetomidine Hydrochloride | Injection | Chemical Drugs(3) | Generic Drug | 2019-10-08 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Approval | 2021-07-05 | view |
CXHS1500094 | 富马酸替诺福韦二吡呋酯胶囊 | tenofovir disoproxil fumarate | Capsule | Chemical Drugs(3.4) | New Drug Application | 2015-10-22 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-04-08 | view |
CYHS1900280 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs(4) | Generic Drug | 2019-04-24 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-04-02 | view |
CYHS1900279 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs(4) | Generic Drug | 2019-04-24 | 成都倍特药业有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | Certificate Issued | 2021-04-02 | view |
CYHS2100306 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-04-01 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Review | 2021-03-31 | view |